Interferon_NP Regulatory_NP Factor_NP 7_CD Regulates_NP Expression_NP of_IN Epstein-Barr_NP Virus_NP Latent_NP Membrane_NP Protein_NP 1_CD :_: a_DT Regulatory_NP Circuit_NP We_PP have_VBP shown_VBN previously_RB that_IN interferon_NN regulatory_JJ factor_NN 7_CD (_( IRF7_JJ )_) ,_, a_DT multifunctional_JJ protein_NN intimately_RB involved_VBN in_IN latent_JJ Epstein-Barr_NP virus_NN (_( EBV_NP )_) infection_NN ,_, is_VBZ induced_VBN as_IN well_RB as_RB activated_VBN by_IN EBV_NP latent_JJ membrane_NN protein_NN 1_CD (_( LMP1_NP )_) ,_, the_DT principal_JJ EBV_NP oncoprotein_NN ._SENT Since_IN the_DT LMP1_JJ promoter_NN (_( LMP1p_NP )_) contains_VBZ an_DT interferon-stimulated_JJ response_NN element_NN (_( ISRE_NP )_) ,_, we_PP hypothesized_VBD that_IN IRF7_NP might_MD be_VB able_JJ to_TO regulate_VB LMP1_JJ expression_NN and_CC thus_RB participate_VB in_IN a_DT regulatory_JJ circuit_NN between_IN these_DT two_CD genes_NNS ._SENT In_IN this_DT study_NN ,_, IRF7_JJ was_VBD shown_VBN first_RB to_TO activate_VB LMP1p_NP in_IN transient_JJ transfection_NN assays_NNS ._SENT Compared_VBN with_IN EBV_NP nuclear_JJ antigen_NN 2_CD (_( EBNA2_NP )_) ,_, the_DT most_RBS potent_JJ viral_JJ transactivator_NN of_IN LMP1p_NP ,_, IRF7_NP has_VBZ a_DT lesser_JJR effect_NN (_( approximately_RB 10_CD %_NN that_IN of_IN EBNA2_NP )_) on_IN induction_NN of_IN LMP1p_NP ._SENT Study_NN with_IN IRF7_JJ deletion_NN mutants_NNS showed_VBD that_IN IRF7_JJ functional_JJ domains_NNS have_VBP similar_JJ effects_NNS on_IN both_CC the_DT beta_JJ interferon_NN (_( IFN-beta_NP )_) and_CC LMP1_JJ promoters_NNS in_IN BJAB_NP and_CC 293_CD cells_NNS ,_, and_CC study_NN with_IN IRF7_JJ phosphomimetic_JJ mutants_NNS showed_VBD that_IN IRF7_JJ phosphorylation_NN may_MD be_VB involved_VBN in_IN the_DT activation_NN of_IN these_DT two_CD promoters_NNS ._SENT Further_RBR ,_, the_DT ISRE_NP in_IN LMP1p_NP responds_VBZ to_TO IRF7_JJ induction_NN and_CC IRF7_JJ binds_NNS to_TO this_DT element_NN ._SENT In_IN the_DT EBV-positive_JJ cell_NN line_NN P3HR1_NP ,_, which_WDT lacks_VBZ the_DT complete_JJ EBNA2_NN and_CC EBV-encoded_JJ leader_NN protein_NN genes_NNS and_CC hence_RB expresses_VBZ low-level_JJ LMP1_NP ,_, IRF7_JJ alone_RB can_MD notably_RB increase_VB the_DT endogenous_JJ LMP1_JJ mRNA_NN and_CC protein_NN levels_NNS ._SENT These_DT results_NNS indicate_VBP that_IN LMP1_NP is_VBZ regulated_VBN by_IN this_DT host_NN cell_NN gene_NN in_IN addition_NN to_TO the_DT viral_JJ factor_NN ,_, EBNA2_NP ,_, and_CC may_MD help_VB to_TO explain_VB how_WRB LMP1_NP is_VBZ expressed_VBN in_IN type_NN II_NP latency_NN in_IN the_DT absence_NN of_IN EBNA2_NP ._SENT Moreover_RB ,_, IRF7_NP can_MD regulate_VB a_DT viral_JJ gene_NN in_IN addition_NN to_TO a_DT host_NN cellular_JJ gene_NN such_JJ as_IN the_DT IFN-beta_NP gene_NN ._SENT Together_RB with_IN the_DT previous_JJ data_NNS that_IN LMP1_NP can_MD induce_VB IRF7_JJ expression_NN and_CC facilitate_VB IRF7_JJ phosphorylation_NN and_CC nuclear_JJ translocation_NN ,_, these_DT results_NNS suggest_VBP a_DT positive_JJ regulatory_JJ circuit_NN between_IN IRF7_JJ and_CC LMP1_JJ ._SENT Interferons_NNS (_( IFNs_NP )_) are_VBP a_DT large_JJ family_NN of_IN multifunctional_JJ secreted_VBN proteins_NNS involved_VBN in_IN antiviral_JJ defense_NN ,_, cell_NN growth_NN regulation_NN ,_, and_CC immune_JJ activation_NN ._SENT The_DT IFN_NP regulatory_JJ factors_NNS (_( IRFs_NP )_) are_VBP a_DT growing_VBG family_NN of_IN virus-_NN and_CC IFN-inducible_JJ cellular_JJ proteins_NNS that_WDT now_RB consists_VBZ of_IN 10_CD members_NNS ,_, including_VBG the_DT recently_RB discovered_VBN IRF-10_NP as_IN well_RB as_IN four_CD Kaposi_NP 's_POS sarcoma-associated_JJ herpesvirus_NN (KSHV)-encoded_VBD viral_JJ IRFs_NNS ._SENT A_DT hallmark_NN of_IN IRF_NP proteins_NNS (_( but_CC not_RB including_VBG viral_JJ IRFs_NNS )_) is_VBZ an_DT N-terminal_JJ DNA-binding_NP domain_NN (_( DBD_NP )_) ,_, which_WDT contains_VBZ a_DT five-tryptophan-residue_NN repeat_NN ._SENT This_DT repeat_NN forms_VBZ a_DT helix-turn-helix_NN motif_NN determining_VBG the_DT characteristic_JJ DNA-binding_NP site_NN ,_, 5'-(A/G)NGAAANNGAAACT-3_NP '_POS ._SENT Distinct_JJ properties_NNS and_CC functions_NNS of_IN IRF_NP family_NN members_NNS depend_VBP on_IN their_PP$ different_JJ C-terminal_JJ sequences_NNS and_CC structures_NNS ._SENT IRFs_NNS are_VBP critical_JJ in_IN the_DT regulation_NN of_IN expression_NN of_IN type_NN I_NP IFNs_NP (_( IFN-alpha_NP and_CC IFN-beta_NP )_) ,_, IFN-stimulated_JJ genes_NNS ,_, and_CC other_JJ cytokines_NNS and_CC chemokines_NNS ;_: three_CD of_IN them_PP ,_, IRF3_NP ,_, IRF5_NP ,_, and_CC IRF7_JJ ,_, are_VBP direct_JJ inducers_NNS of_IN virus-mediated_JJ signaling_VBG ._SENT IRF7_JJ was_VBD cloned_VBN and_CC identified_VBN within_IN the_DT biologic_JJ context_NN of_IN Epstein-Barr_NP virus_NN (_( EBV_NP )_) latency_NN and_CC is_VBZ expressed_VBN predominately_RB in_IN spleen_NN ,_, thymus_NN ,_, and_CC peripheral_JJ blood_NN leukocytes_NNS ._SENT IRF7_JJ has_VBZ been_VBN implicated_VBN in_IN IFN_NP gene_NN activation_NN in_IN response_NN to_TO virus_NN infection_NN ._SENT In_IN addition_NN to_TO IFNs_NP ,_, IRF7_JJ expression_NN is_VBZ also_RB stimulated_VBN by_IN other_JJ factors_NNS such_JJ as_IN sodium_NN butyrate_NN ,_, lipopolysaccharide_NN ,_, topoisomerase_JJ II_NP inhibitors_NNS ,_, 12-O-tetra-decanoylphorbol-13-acetate_JJ (_( TPA_NP )_) ,_, and_CC tumor_NN necrosis_NN factor_NN alpha_NN (_( TNF-alpha_NP )_) ._SENT Cellular_JJ factors_NNS ,_, including_VBG NF-kappaB_NP ,_, are_VBP involved_VBN in_IN the_DT induction_NN of_IN IRF7_JJ by_IN TNF-alpha_NP ._SENT Interestingly_RB ,_, IRF7_JJ also_RB can_MD be_VB induced_VBN by_IN the_DT principal_JJ EBV_NP oncoprotein_NP ,_, latent_JJ membrane_NN protein_NN 1_CD (_( LMP1_NP )_) ._SENT IRF7_JJ appears_VBZ to_TO be_VB a_DT multifunctional_JJ protein_NN involved_VBN in_IN multiple_JJ physiological_JJ processes_NNS during_IN viral_JJ infection_NN ,_, including_VBG regulation_NN of_IN the_DT host_NN immune_JJ system_NN ,_, IFN_NP gene_NN expression_NN ,_, and_CC EBV_NP latency_NN ,_, as_RB well_RB as_IN acting_VBG as_IN a_DT putative_JJ oncogene_NN (_( L._NP Zhang_NP ,_, C._NP Der_NP ,_, and_CC J._NP S._NP Pagano_NP ,_, unpublished_JJ results_NNS )_) ._SENT IRF7_JJ has_VBZ also_RB been_VBN reported_VBN to_TO participate_VB in_IN monocyte_NN differentiation_NN ._SENT EBV_NP LMP1_NP is_VBZ an_DT integral_JJ membrane_NN protein_NN with_IN six_CD transmembrane_NN N-terminal_JJ domains_NNS and_CC a_DT long_JJ C-terminal_JJ cytoplasmic_JJ tail_NN ._SENT LMP1_NP ,_, as_IN a_DT key_JJ EBV_NP oncogenic_JJ factor_NN ,_, is_VBZ a_DT constitutively_RB active_JJ receptor-like_JJ molecule_NN that_WDT does_VBZ not_RB need_VB the_DT binding_NN of_IN a_DT ligand_NN ._SENT Expression_NN of_IN LMP1_NP is_VBZ essential_JJ for_IN growth_NN transformation_NN of_IN B_NP lymphocytes_NNS ._SENT Several_JJ studies_NNS have_VBP demonstrated_VBN that_IN efficient_JJ LMP1_JJ promoter_NN activation_NN is_VBZ dependent_JJ upon_IN virus-specific_JJ factors_NNS ;_: some_DT host_NN cellular_JJ factors_NNS are_VBP also_RB involved_VBN in_IN these_DT processes_NNS (_( ,_, ,_, ,_, -_: ,_, )_) ._SENT EBV_NP nuclear_JJ antigen_NN 2_CD (_( EBNA2_NP )_) is_VBZ the_DT best-characterized_JJ viral_JJ factor_NN that_WDT transactivates_VBZ the_DT LMP1_JJ promoter_NN (_( LMP1p_NP )_) ._SENT Also_RB ,_, EBV-encoded_JJ leader_NN protein_NN (_( EBNA-LP_NP )_) can_MD activate_VB the_DT LMP1p_NP ,_, especially_RB in_IN cooperation_NN with_IN EBNA2_NP ._SENT In_IN addition_NN to_TO LMP1p_NP ,_, it_PP is_VBZ well_RB established_VBN that_IN EBNA2_NP can_MD transactivate_VB a_DT number_NN of_IN other_JJ genes_NNS ,_, including_VBG the_DT cellular_JJ CD21_NP ,_, CD23_NP ,_, c-Bcl-2_NP ,_, and_CC c-fgr_NP and_CC EBV_NP LMP2A_NP and_CC LMP2B_NP genes_NNS and_CC the_DT EBNA-1_NP C_NP promoter_NN ._SENT EBNA2_NP does_VBZ not_RB bind_VB directly_RB to_TO DNA_NN but_CC exerts_VBZ its_PP$ function_NN by_IN interacting_VBG with_IN the_DT cellular_JJ protein_NN ,_, recombination_NN signal-binding_NN protein_NN (_( RBP-Jkappa_NP )_) ,_, and_CC PU.1_JJ protein_NN ;_: other_JJ cellular_JJ transcriptional_JJ factors_NNS mediate_VBP the_DT activation_NN of_IN LMP1_NP by_IN EBNA2_NP ._SENT The_DT latency-associated_JJ nuclear_JJ antigen_NN encoded_VBN by_IN KSHV_NP can_MD also_RB activate_VB LMP1p_NP ._SENT LMP1_NP stimulates_VBZ the_DT expression_NN of_IN IRF7_JJ ,_, ICAM-1_NP ,_, LFA-3_NP ,_, CD40_NP ,_, EBI-3_NP ,_, the_DT transporter_NN associated_VBN with_IN antigen_NN processing_NN 2_CD (_( Tap-2_NP )_) ,_, Fas_NP ,_, and_CC TNF_NP receptor-associated_JJ factor_NN 1_CD in_IN EBV-negative_NP Burkitt_NP 's_POS lymphoma_NN (_( BL_NP )_) cells_NNS and_CC of_IN the_DT epidermal_JJ growth_NN receptor_NN in_IN epithelial_JJ cells_NNS (_( ,_, -_: ,_, ,_, )_) ._SENT LMP1_NP also_RB induces_VBZ or_CC enhances_VBZ expression_NN of_IN matrix_NN metalloproteinase_NN 1_CD ,_, matrix_NN metalloproteinase_NN 9_CD ,_, Bcl-2_NP ,_, cyclooxygenase-2_NN ,_, and_CC vascular_JJ endothelial_JJ growth_NN factor_NN as_RB well_RB as_IN fibroblast_NN growth_NN factor_NN 2_CD and_CC hypoxia-inducible_JJ factor_NN 1alpha_NP (_( N._NP S._NP Wakisaka_NP and_CC J._NP S._NP Pagano_NP ,_, unpublished_JJ results_NNS )_) ,_, all_DT of_IN which_WDT are_VBP associated_VBN with_IN tumor_NN invasion_NN and_CC metastasis_NN ._SENT Therefore_RB ,_, LMP1_NP is_VBZ a_DT key_JJ mediator_NN for_IN host_NN viral_JJ defense_NN as_RB well_RB as_IN oncogenesis_NN ._SENT Because_IN of_IN a_DT conserved_VBN DBD_NN in_IN the_DT N-terminal_JJ region_NN of_IN all_DT members_NNS of_IN the_DT IRF_NP family_NN ,_, IRFs_NP can_MD bind_VB to_TO consensus_NN or_CC similar_JJ sequences_NNS :_: IFN-stimulated_JJ response_NN element_NN (_( ISRE_NP )_) ,_, positive_JJ regulatory_JJ element_NN ,_, and_CC IFN_NP consensus_NN sequence_NN ,_, all_DT of_IN which_WDT have_VBP conserved_VBN GAAA_NP repeats_NNS ._SENT LMP1_NP has_VBZ an_DT ISRE_NN within_IN its_PP$ promoter_NN ._SENT In_IN this_DT paper_NN ,_, we_PP show_VBP that_IN IRF7_NP can_MD bind_VB to_TO and_CC regulate_VB the_DT LMP1_JJ promoter_NN and_CC that_IN IRF7_NP can_MD stimulate_VB expression_NN of_IN LMP1_JJ mRNA_NN and_CC protein_NN independently_RB of_IN as_RB well_RB as_RB cooperatively_RB with_IN EBNA2_NP ._SENT Plasmids_NNS ._SENT |_SYM The_DT LMP1_JJ promoter_NN construct_NN pGL2(-512/+72)-luciferase_NN plasmid_NN ,_, which_WDT has_VBZ two_CD directly_RB repeated_VBN copies_NNS of_IN the_DT LMP1_JJ -512/+72_JJ promoter_NN element_NN ,_, was_VBD provided_VBN by_IN Jeffery_NP Lin_NP and_CC Elliott_NP Kieff_NP ._SENT The_DT LMP1_NP promoter_NN construct_NN pgLRS(-259)-CAT_NN and_CC its_PP$ mutations_NNS ,_, pgLRS(-259)-ISRE--CAT_NN ,_, pgLRS(-259)-Jkappa--CAT_NN ,_, and_CC pgLRS(-259)-ISRE-/Jkappa--CAT_NN ,_, were_VBD gifts_NNS from_IN Anna_NP Sjoblom_NP and_CC Lars_NP Rymo_NP ._SENT The_DT wild-type_JJ IRF7A_NP expression_NN plasmid_NP pcDNA3/IRF7A_NP was_VBD constructed_VBN in_IN this_DT laboratory_NN ._SENT The_DT IFN-beta_NP promoter_NN (_( IFNbetap_NP )_) construct_VB (_( pGL3/IFNbetap-Luc_NN )_) and_CC a_DT series_NN of_IN pCMV2-Flag_NN plasmids_NNS containing_VBG wild-type_NP IRF7A_NP and_CC its_PP$ deletion_NN or_CC substitution_NN mutations_NNS were_VBD described_VBN previously_RB and_CC were_VBD gifts_NNS from_IN Rongtuan_NP Lin_NP and_CC John_NP Hiscott_NP ._SENT The_DT pBS-LMP1_JJ plasmid_NN for_IN RNase_NP protection_NN assays_NNS (_( RPA_NP )_) was_VBD provided_VBN by_IN Paul_NP Farrell_NP ._SENT The_DT EBNA2-expressing_NP plasmid_NP construct_NN was_VBD made_VBN by_IN inserting_VBG a_DT 2.1-kb_JJ MluI-AhaIII_NP restriction_NN fragment_NN containing_VBG the_DT EBNA2b_NP coding_VBG region_NN from_IN the_DT AG876_NP virus_NN into_IN the_DT pGEM_NN derivative_JJ pHD_NN 101-3_CD ._SENT IRF7-DN_NP ,_, which_WDT lacks_VBZ the_DT DBD_NN of_IN the_DT human_JJ IRF7A_NP gene_NN ,_, was_VBD provided_VBN by_IN Tom_NP Maniatis_NP ._SENT Cell_NN lines_NNS ._SENT |_SYM BJAB_NP is_VBZ an_DT EBV-negative_JJ human_JJ BL_NP cell_NN line_NN ._SENT P3HR-1_NP ,_, an_DT EBV-positive_JJ cell_NN line_NN from_IN which_WDT portions_NNS of_IN the_DT EBNA-LP_NP and_CC EBNA2_NP open_JJ reading_NN frames_NNS have_VBP been_VBN deleted_VBN ,_, expresses_VBZ low_JJ levels_NNS of_IN LMP1_NP ._SENT Both_DT BJAB_NP and_CC P3HR1_NP cells_NNS were_VBD grown_VBN in_IN RPMI_NP 1640_CD medium_NN supplemented_VBN with_IN 10_CD %_NN fetal_JJ bovine_JJ serum_NN (_( FBS_NP )_) and_CC penicillin-streptomycin_NN (_( 5_CD U/ml_NP and_CC 5_CD mug/ml_NN ,_, respectively_RB )_) ._SENT The_DT 293_CD cell_NN line_NN (_( derived_VBN from_IN human_JJ kidney_NN epithelial_JJ cells_NNS )_) was_VBD grown_VBN in_IN Dulbecco_NP 's_POS modified_JJ Eagle_NP 's_POS medium_NN with_IN 10_CD %_NN FBS_NP and_CC penicillin-streptomycin_NP (_( 5_CD U/ml_NP and_CC 5_CD mug/ml_NN ,_, respectively_RB )_) ._SENT Transfections_NNS ._SENT |_SYM BJAB_NP and_CC P3HR-1_NP cells_NNS were_VBD transfected_VBN with_IN an_DT electroporator_NN at_IN 210_CD V_CD and_CC 975_CD muF_NN with_IN 5-mug_JJ quantities_NNS of_IN the_DT various_JJ promoter_NN constructs_NNS or_CC vector_NN and_CC increasing_VBG concentrations_NNS of_IN the_DT IRF7_JJ clones_NNS in_IN 0.5_CD ml_NN of_IN RPMI_NP 1640_CD medium_NN containing_VBG 10_CD %_NN FBS_NP ._SENT Vector_NP DNA_NP was_VBD added_VBN to_TO equalize_VB the_DT total_JJ amount_NN of_IN DNA_NN used_VBN in_IN all_DT transfections_NNS ._SENT After_IN electroporation_NN ,_, cells_NNS were_VBD resuspended_VBN in_IN 10_CD ml_NN of_IN complete_JJ medium_NN and_CC incubated_VBN for_IN 48_CD h._NP Cells_NP were_VBD harvested_VBN ,_, washed_VBN twice_RB with_IN phosphate-buffered_JJ saline_NN ,_, and_CC lysed_VBN in_IN appropriate_JJ buffer_NN ._SENT Reporter_NN assays_NNS ._SENT |_SYM For_IN luciferase_NN assays_NNS ,_, the_DT transfected_JJ cells_NNS were_VBD collected_VBN at_IN 48_CD h_NN posttransfection_NN and_CC resuspended_JJ in_IN 200_CD mul_NN of_IN 1x_NP reporter_NN lysis_NN buffer_NN (_( Promega_NP )_) ._SENT The_DT cells_NNS were_VBD placed_VBN in_IN a_DT dry_JJ ice-isopropanol_NN bath_NN for_IN 2_CD min_NN ,_, thawed_VBN at_IN 37C_JJ ,_, vortexed_JJ ,_, and_CC then_RB centrifuged_VBN at_IN 16,000_CD x_NN g_NN for_IN 20_CD s._JJ Cell_JJ lysates_NNS (_( 20_CD mul_NN each_DT )_) were_VBD combined_VBN with_IN luciferase_NN assay_NN reagent_NN (_( Promega_NP )_) ,_, and_CC the_DT relative_JJ light_JJ units_NNS (_( RLU_NP )_) were_VBD measured_VBN in_IN an_DT Lmax_NP luminometer_NN (_( Molecular_NP Devices_NPS Corp._NP )_) ._SENT The_DT pcDNA3_JJ empty_JJ vector_NN alone_RB was_VBD used_VBN in_IN these_DT assays_NNS to_TO determine_VB the_DT ability_NN of_IN IRF7_JJ to_TO activate_VB the_DT vector_NN alone_RB ,_, and_CC the_DT transfection_NN efficiencies_NNS were_VBD normalized_VBN by_IN beta-galactosidase_NN (_( beta-Gal_JJ )_) values_NNS ._SENT Chloramphenicol_NN acetyltransferase_NN (_( CAT_NP )_) assays_NNS were_VBD performed_VBN as_IN described_VBN previously_RB ;_: results_NNS were_VBD analyzed_VBN by_IN use_NN of_IN ImageQuant_NP software_NN (_( version_NN 5_CD ;_: Molecular_NP Dynamics_NPS )_) ._SENT All_DT reporter_NN assay_NN results_NNS presented_VBN are_VBP from_IN single_JJ experiments_NNS representative_NN of_IN multiple_JJ independent_JJ trials_NNS or_CC are_VBP averages_NNS derived_VBN from_IN multiple_JJ independent_JJ repetitions_NNS ._SENT Western_JJ blotting_VBG with_IN enhanced_JJ chemiluminescence_NN detection_NN ._SENT |_SYM Cells_NP were_VBD collected_VBN and_CC washed_VBN with_IN 5_CD ml_NN of_IN phosphate-buffered_JJ saline_NN ._SENT The_DT pellets_NNS were_VBD resuspended_VBN in_IN 200_CD mul_NN of_IN cell_NN lysis_NN buffer_NN and_CC mixed_VBN with_IN 200_CD mul_NN of_IN 2x_JJ sodium_NN dodecyl_NN sulfate_NN loading_NN buffer_NN ._SENT Lysates_NNS were_VBD separated_VBN on_IN sodium_NN dodecyl_NN sulfate-10_NN %_NN polyacrylamide_NN electrophoresis_NN gels_NNS for_IN detection_NN of_IN IRF7_JJ and_CC LMP1_JJ and_CC 8_CD %_NN gels_NNS for_IN EBNA2_NP ._SENT The_DT proteins_NNS were_VBD then_RB transferred_VBN to_TO nitrocellulose_NN membranes_NNS ._SENT The_DT membranes_NNS were_VBD blocked_VBN in_IN 5_CD %_NN milk_NN for_IN 1_CD h_NN at_IN room_NN temperature_NN (_( RT_NP )_) ,_, rinsed_VBN in_IN Tris-buffered_JJ saline_NN with_IN Tween_NP (_( TBST_NP )_) three_CD times_NNS for_IN 5_CD min_NN each_DT time_NN ,_, and_CC then_RB incubated_VBN with_IN the_DT specific_JJ primary_JJ antibody_NN at_IN RT_NP for_IN 1_CD h_NN or_CC at_IN 4C_JJ overnight_JJ ._SENT After_IN three_CD rinses_NNS for_IN 5_CD min_NN each_DT rinse_NN in_IN TBST_NP ,_, the_DT membranes_NNS were_VBD incubated_VBN with_IN appropriate_JJ horseradish_NN peroxidase-conjugated_VBD secondary_JJ antibodies_NNS (_( Amersham_NP Biosciences_NP )_) (_( 1:3,000_CD )_) for_IN 1_CD h_NN at_IN RT_NP and_CC subsequently_RB washed_VBN with_IN TBST_NP three_CD times_NNS for_IN 5_CD min_NN each_DT time_NN ._SENT Specific_JJ signals_NNS were_VBD detected_VBN by_IN enhanced_JJ chemiluminescence_NN (_( ECL_NN )_) following_VBG the_DT manufacturer_NN 's_POS instruction_NN (_( Amersham_NP Pharmacia_NP Biotech_NP )_) ._SENT IRF7_JJ was_VBD detected_VBN with_IN rabbit_NN polyclonal_JJ antibody_NN (_( Santa_NP Cruz_NP )_) (_( 1:300_CD )_) ,_, and_CC EBNA2_NP ,_, LMP1_NP ,_, and_CC Flag_NP were_VBD detected_VBN with_IN mouse_NN monoclonal_NN antibodies_NNS PE2_JJ (_( DAKO_NP )_) (_( 1:500_CD )_) ,_, CS1-4_NP (_( DAKO_NP )_) (_( 1:100_CD )_) ,_, and_CC M2_NP (_( Sigma_NP )_) (_( 1:3,000_CD )_) ,_, respectively_RB ._SENT EMSA_NP ._SENT |_SYM BJAB_NP and_CC 293_CD cells_NNS in_IN 100-mm-diameter_NN dishes_NNS were_VBD transfected_VBN with_IN 5_CD mug_NN of_IN Flag-tagged_NP IRF7A_NP or_CC its_PP$ mutants_NNS ._SENT Cells_NNS were_VBD collected_VBN and_CC lysed_VBN in_IN binding_JJ buffer_NN (_( 10_CD mM_NP Tris-HCl_NP [_SYM pH_NN 7.5_CD ]_SYM ,_, 1_CD mM_NP EDTA_NP ,_, 50_CD mM_NP NaCl_NP ,_, 2_CD mM_JJ dithiothreitol_NN [_SYM DTT_NP ]_SYM ,_, 5_CD %_NN glycerol_NN ,_, 0.5_CD %_NN NP-40_NP ,_, 10_CD mug_NN of_IN bovine_JJ serum_NN albumin_NN [_SYM BSA]/mul_NP )_) with_IN protease_NN inhibitors_NNS at_IN 48_CD h_NN posttransfection_NN ._SENT The_DT whole-cell_NN lysates_NNS were_VBD used_VBN for_IN electrophoretic_JJ mobility_NN shift_NN assays_NNS (_( EMSA_NP )_) ,_, as_RB described_VBN previously_RB ._SENT Poly(dI-dC)_NP (_( Amersham_NP )_) at_IN a_DT final_JJ concentration_NN of_IN 62.5_CD mug/ml_NN was_VBD added_VBN to_TO reduce_VB nonspecific_JJ binding_NN ._SENT The_DT double-stranded_JJ sequence_NN containing_VBG LMP1_NP ISRE_NP is_VBZ GATCCAACAGGAAATGGAAAGGCAGTG_NP ._SENT Another_DT sequence_NN containing_VBG mutated_VBN LMP1_NP ISRE_NP is_VBZ GATCCAACAGGAggTGGAggGGCAGTG_NP (_( the_DT mutated_VBN nucleotides_NNS are_VBP indicated_VBN by_IN lowercase_JJ letters_NNS )_) ._SENT These_DT double-stranded_JJ sequences_NNS with_IN 5'-GATC_JJ adhesive_JJ ends_NNS were_VBD labeled_VBN (_( using_VBG Klenow_NP fragments_NNS )_) with_IN [_SYM alpha-32P]dCTP_NN ._SENT For_IN competitor_NN assays_NNS ,_, 100-fold_JJ excess_JJ cold_JJ probe_NN or_CC AP-1_JJ sequence_NN (_( Promega_NP )_) was_VBD added_VBN to_TO the_DT binding_JJ mixture_NN ._SENT For_IN supershift_NN assays_NNS ,_, whole-cell_NN lysates_NNS were_VBD incubated_VBN with_IN 0.2_CD mug_NN of_IN Flag_NP antibody_NN M2_NP (_( Sigma_NP )_) before_IN probe_NN was_VBD added_VBN ._SENT Protein-DNA_NP complexes_NNS were_VBD separated_VBN on_IN 5_CD %_NN 60:1_CD acrylamide_NN gels_NNS ._SENT RNA_NP isolation_NN and_CC RPA_NP ._SENT |_SYM P3HR1_JJ cells_NNS were_VBD transfected_VBN with_IN different_JJ amounts_NNS of_IN IRF7_JJ and_CC EBNA2_JJ expression_NN plasmids_NNS together_RB with_IN CD4_NP expression_NN plasmid_NN ._SENT Using_VBG a_DT QIAgen_NP RNeasy_NP mini_JJ kit_NN ,_, total_JJ RNAs_NP were_VBD isolated_VBN from_IN CD4-conjugated_JJ magnetic_JJ bead_NN (Dynal)-selected_JJ cells_NNS ._SENT RPA_NP were_VBD performed_VBN with_IN total_JJ RNA_NP using_VBG an_DT RNase_NP protection_NN kit_NN II_NP (_( Ambion_NP )_) ._SENT The_DT hybridization_NN temperature_NN was_VBD 37C_JJ ._SENT The_DT human_JJ GAPDH_NP probe_NN was_VBD supplied_VBN by_IN US_NP Biochemicals_NP Inc._NP The_DT LMP1_JJ probe_NN for_IN RPA_NP ,_, which_WDT was_VBD from_IN the_DT pBS-LMP1_JJ construct_NN and_CC labeled_VBN with_IN [_SYM alpha-32P]UTP_NN by_IN in_IN vitro_NN transcription_NN ,_, corresponds_VBZ to_TO nucleotides_NNS 169033_CD to_TO 169423_CD in_IN the_DT B95-8_NP EBV_NP genome_NN ._SENT The_DT protected_JJ fragments_NNS were_VBD 220_CD and_CC 90_CD bp_NN ._SENT IRF7_JJ upregulates_NNS the_DT LMP1_JJ promoter_NN ._SENT |_SYM The_DT positive_JJ regulators_NNS of_IN the_DT LMP1_JJ promoter_NN (_( LMP1p_NP )_) identified_VBD to_TO date_VB center_NN mostly_RB on_IN the_DT EBNA2-responsive_JJ enhancer_NN region_NN to_TO which_WDT RBP-Jkappa_NP binds_VBZ ._SENT Here_RB ,_, we_PP examined_VBD whether_IN another_DT region_NN of_IN LMP1p_NP that_WDT contains_VBZ an_DT ISRE_NP would_MD be_VB responsive_JJ to_TO induction_NN by_IN IRF7_JJ ._SENT BJAB_NP ,_, an_DT EBV-negative_JJ human_JJ BL_NP cell_NN line_NN ,_, was_VBD used_VBN for_IN this_DT study_NN because_IN it_PP has_VBZ little_JJ endogenous_JJ IRF7_JJ ._SENT The_DT assayed_VBN LMP1p_NP construct_NN ,_, pLMP1(-512/+72)_NN ,_, has_VBZ two_CD directly_RB repeated_VBN copies_NNS of_IN the_DT LMP1_JJ -512/+72_JJ promoter_NN element_NN ._SENT Using_VBG luciferase_NN assays_NNS ,_, we_PP examined_VBD the_DT effect_NN of_IN the_DT presence_NN of_IN IRF7_JJ on_IN the_DT regulation_NN of_IN LMP1p_NP after_IN transient_JJ expression_NN of_IN IRF7_JJ ._SENT In_IN cells_NNS transfected_VBN with_IN IRF7A_NP ,_, LMP1p_NP activity_NN was_VBD increased_VBN about_IN 10-fold_NN compared_VBN with_IN that_DT produced_VBN by_IN the_DT vector_NN pcDNA3_NN alone_RB ._SENT The_DT regulatory_JJ effects_NNS were_VBD clearly_RB dose_NN dependent_JJ ,_, with_IN increasing_VBG amounts_NNS of_IN IRF7A_NP resulting_VBG in_IN elevated_JJ levels_NNS of_IN luciferase_NN activity_NN ._SENT In_IN this_DT assay_NN ,_, EBNA2_NP ,_, which_WDT is_VBZ known_VBN to_TO transactivate_JJ LMP1p_NP ,_, was_VBD used_VBN as_IN a_DT positive_JJ control_NN ._SENT Compared_VBN with_IN IRF7_JJ ,_, EBNA2_NP had_VBD a_DT greater_JJR effect_NN on_IN transactivation_NN of_IN LMP1p_NP (_( up_RB to_TO 100-fold_NN with_IN 5_CD mug_NN of_IN EBNA2_NP expression_NN plasmid_NN )_) ._SENT However_RB ,_, the_DT cotransfection_NN of_IN IRF7A_NP and_CC EBNA2_NP resulted_VBD in_IN up_RB to_TO 200-fold_JJ activation_NN of_IN LMP1p_NP ;_: the_DT combined_JJ effect_NN was_VBD generally_RB greater_JJR than_IN the_DT effect_NN of_IN IRF7_JJ alone_JJ plus_CC that_IN of_IN EBNA2_NP alone_RB ._SENT Thus_RB ,_, LMP1p_NP can_MD respond_VB to_TO induction_NN by_IN IRF7_JJ independently_RB of_IN the_DT EBNA2_NP enhancer_NN region_NN ,_, and_CC the_DT two_CD can_MD function_VB together_RB to_TO activate_VB the_DT promoter_NN ._SENT Western_JJ blot_NN analyses_NNS show_VBP that_IN exogenous_JJ IRF7_JJ was_VBD expressed_VBN in_IN the_DT transfected_JJ BJAB_NP cells_NNS and_CC that_IN a_DT low_JJ level_NN of_IN endogenous_JJ IRF7_JJ is_VBZ detected_VBN in_IN these_DT cells_NNS (_( Fig._NN ,_, first_JJ lane_NN )_) ._SENT To_TO elaborate_VB on_IN the_DT significance_NN of_IN the_DT results_NNS obtained_VBN with_IN BJAB_NP cells_NNS ,_, we_PP tested_VBD the_DT effects_NNS of_IN IRF7_JJ on_IN LMP1p_NP in_IN another_DT human_JJ cell_NN line_NN ,_, 293_CD ._SENT These_DT cells_NNS contain_VBP no_DT detectable_JJ endogenous_JJ IRF7_JJ and_CC EBNA2_JJ ,_, and_CC LMP1p_NP constructs_NNS cannot_MD be_VB activated_VBN by_IN endogenous_JJ factors_NNS in_IN 293_CD cells_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT Luciferase_NN assays_NNS show_VBP that_IN IRF7_NP can_MD activate_VB LMP1p_NP in_IN 293_CD cells_NNS ._SENT However_RB ,_, the_DT effect_NN is_VBZ less_RBR striking_JJ than_IN in_IN BJAB_NP cells_NNS ._SENT IRF7_NP consistently_RB activates_VBZ LMP1p_NP in_IN 293_CD cells_NNS at_IN levels_NNS two-_NN to_TO threefold_RB higher_JJR than_IN those_DT seen_VBN with_IN the_DT vector-only_JJ control_NN ._SENT The_DT effect_NN is_VBZ approximately_RB threefold_RB less_JJR than_IN that_DT obtained_VBN with_IN BJAB_NP cells_NNS ._SENT IRF7_JJ functional_JJ domains_NNS and_CC phosphorylation_NN in_IN LMP1p_NP activation_NN ._SENT |_SYM Functional_JJ domains_NNS of_IN IRF7_JJ protein_NN have_VBP been_VBN defined_VBN based_VBN on_IN effects_NNS of_IN mutated_VBN IRF7_JJ on_IN the_DT IFNA4_NP ,_, IFN-beta_NP ,_, and_CC RANTES_NP promoters_NNS ._SENT This_DT study_NN showed_VBD that_IN the_DT C_NP terminus_NN of_IN IRF7_JJ protein_NN contains_VBZ a_DT constitutive_JJ activation_NN domain_NN (_( CAD_NP )_) ,_, a_DT signal_NN response_NN domain_NN ,_, a_DT virus-inducible_JJ activity_NN domain_NN (_( VAD_NN )_) ,_, and_CC an_DT inhibition_NN domain_NN (_( ID_NP )_) ,_, as_RB shown_VBN in_IN Fig._NN ._SENT Also_RB ,_, a_DT nuclear_JJ export_NN sequence_NN (_( NES_NP )_) was_VBD identified_VBN between_IN amino_NN acids_NNS 416_CD and_CC 467_CD which_WDT overlaps_VBZ with_IN the_DT ID_NN ._SENT To_TO check_VB whether_IN these_DT functional_JJ domains_NNS have_VBP similar_JJ functions_NNS for_IN LMP1p_NP ,_, we_PP transfected_VBD IRF7_JJ domain_NN deletion_NN mutants_NNS IRF7(Delta247-467)_NN (_( designated_VBN as_IN IRF-DeltaID_NP )_) ,_, IRF7(Delta151-278)_NP (_( IRF7-DeltaCAD_NP )_) ,_, IRF7(Delta247-372)_NP (_( IRF7-DeltaVAD_NP )_) ,_, IRF7(Delta151-467)_NP (_( IRF7-DeltaCAD/ID_NP )_) ,_, and_CC IRF7(Delta416-467)_NP (_( IRF7-DeltaNES_NP )_) ,_, together_RB with_IN the_DT LMP1p_NP construct_NN pLMP1_NN (_( -512/+72_NN )_) or_CC the_DT IFNbetap_NP construct_NN pGL3/IFNbetap-Luc_NN ,_, in_IN 293_CD cells_NNS ._SENT Interestingly_RB ,_, these_DT IRF7_JJ functional_JJ domains_NNS have_VBP similar_JJ functional_JJ effects_NNS on_IN two_CD different_JJ promoters_NNS ,_, IFNbetap_NP and_CC LMP1p_NP ,_, in_IN the_DT same_JJ cell_NN line_NN ,_, 293_CD ._SENT IRF-DeltaID_NP has_VBZ a_DT higher_JJR level_NN of_IN activation_NN ability_NN than_IN wild-type_NN IRF7_JJ for_IN both_DT IFNbetap_NP and_CC LMP1p_NP ,_, although_IN the_DT level_NN of_IN activation_NN is_VBZ much_RB higher_JJR for_IN IFNbetap_NP than_IN for_IN LMP1p_NP ._SENT Although_IN deletion_NN of_IN the_DT VAD_NN (_( IRF7-DeltaVAD_NP )_) impaired_JJ transactivation_NN greatly_RB ,_, the_DT VAD_NN is_VBZ not_RB necessary_JJ for_IN retention_NN of_IN IRF7_JJ activity_NN in_IN the_DT absence_NN of_IN virus_NN infection_NN ,_, since_IN IRF7-DeltaID_NN (_( Delta247-467_JJ )_) without_IN the_DT VAD_NN also_RB has_VBZ very_RB high_JJ constitutive_JJ activity_NN ._SENT In_IN contrast_NN ,_, the_DT CAD_NP is_VBZ necessary_JJ for_IN constitutive_JJ IRF7_JJ activity_NN ._SENT All_PDT the_DT other_JJ deletion_NN mutants_NNS have_VBP lower_JJR activation_NN capabilities_NNS than_IN wild-type_NN IRF7_JJ ,_, and_CC IRF7-DeltaNES_NP almost_RB abolished_VBD activation_NN of_IN LMP1p_NP ._SENT The_DT dominant-negative_JJ mutant_NN ,_, IRF7-DN_NP ,_, which_WDT lacks_VBZ the_DT DBD_NN ,_, cannot_MD activate_VB LMP1p_NP ,_, indicating_VBG that_IN direct_JJ or_CC indirect_JJ binding_NN of_IN IRF7_JJ to_TO LMP1p_NP is_VBZ necessary_JJ for_IN LMP1p_NP activation_NN ._SENT Similar_JJ results_NNS were_VBD obtained_VBN with_IN BJAB_NP cells_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT The_DT sequence_NN and_CC phenotype_NN of_IN each_DT of_IN the_DT IRF7A_NP point_NN mutants_NNS with_IN serines_NNS replaced_VBN by_IN phosphomimetic_JJ aspartic_JJ acids_NNS ,_, IRF7(D483/487)_NP ,_, IRF7(D475-479)_NP ,_, and_CC IRF7(D477/479)_NP ,_, are_VBP shown_VBN in_IN Fig._NN ._SENT These_DT substitution_NN mutants_NNS show_VBP that_IN serines_NNS at_IN different_JJ sites_NNS have_VBP different_JJ functional_JJ capacities_NNS in_IN LMP1p_NP induction_NN ._SENT IRF7(D483/487)_NP produced_VBD much_RB less_JJR induction_NN than_IN wild-type_NP IRF7A_NP ;_: however_RB ,_, IRF7(D477/479)_NP has_VBZ much_RB higher_JJR inducing_VBG ability_NN ._SENT Substitution_NN of_IN two_CD more_JJR serines_NNS at_IN serine-475_NN and_CC serine-476_JJ (_( D475-479_NP )_) did_VBD not_RB result_VB in_IN a_DT higher_JJR level_NN of_IN activity_NN ._SENT The_DT results_NNS suggest_VBP that_IN only_JJ phosphorylation_NN of_IN serine-477_JJ and_CC serine-479_NN is_VBZ necessary_JJ for_IN LMP1p_NP activation_NN in_IN the_DT absence_NN of_IN virus_NN infection_NN ._SENT Western_JJ blot_NN analysis_NN shows_VBZ that_IN IRF7_JJ and_CC its_PP$ mutants_NNS are_VBP all_RB expressed_VBN in_IN the_DT transfected_JJ cells_NNS ._SENT The_DT bulk_NN of_IN each_DT mutated_VBN protein_NN was_VBD located_VBN in_IN the_DT nucleus_NN ,_, except_IN for_IN IRF7-DeltaID_NP and_CC IRF7-DeltaNES_NP ,_, both_DT of_IN which_WDT were_VBD located_VBN only_RB in_IN the_DT nucleus_NN with_IN none_NN of_IN either_RB detected_VBN in_IN the_DT cytoplasmic_JJ extracts_VBZ (_( data_NNS not_RB shown_VBN )_) ._SENT The_DT ISRE_NP of_IN LMP1p_NP responds_VBZ to_TO IRF7_JJ ._SENT |_SYM The_DT LMP1_JJ regulatory_JJ sequence_NN (_( LRS_NP )_) is_VBZ defined_VBN as_IN nucleotides_NNS 169477_CD to_TO 170151_CD of_IN the_DT B95-8_NP genome_NN ,_, which_WDT corresponds_VBZ to_TO -634_CD to_TO +40_NN relative_JJ to_TO the_DT LMP1_JJ transcription_NN start_NN site_NN ._SENT Because_IN IRF7_JJ can_MD bind_VB to_TO ISRE-like_JJ elements_NNS ,_, we_PP tested_VBD whether_IN the_DT ISRE_NP element_NN in_IN LMP1p_NP is_VBZ responsive_JJ to_TO IRF7_JJ ._SENT BJAB_NN cells_NNS were_VBD transfected_VBN with_IN pcDNA3/IRF7A_NN expression_NN plasmid_NN together_RB with_IN pgLRS(-259)-CAT_NN LMP1p_NN constructs_NNS and_CC its_PP$ mutants_NNS ._SENT As_IN expected_VBN ,_, both_DT pgLRS(-259)-CAT_NN (_( wild_JJ type_NN )_) and_CC the_DT pgLRS(-259)-RBP-Jkappa--CAT_NN mutant_NN have_VBP similar_JJ activities_NNS after_IN IRF7_JJ induction_NN ;_: however_RB ,_, both_CC the_DT pgLRS(-259)-ISRE--CAT_NN mutant_NN and_CC the_DT pgLRS(-259)-ISRE-/RBP-Jkappa--CAT_NN mutant_NN could_MD not_RB be_VB activated_VBN by_IN IRF7_JJ ._SENT From_IN these_DT data_NNS ,_, we_PP can_MD conclude_VB that_IN the_DT ISRE_NP ,_, not_RB the_DT RBP-Jkappa_NP binding_JJ site_NN in_IN LMP1p_NP ,_, is_VBZ the_DT target_NN for_IN IRF7_JJ ._SENT IRF7_JJ binds_NNS to_TO the_DT ISRE_NP of_IN LMP1p_NP ._SENT |_SYM Further_NP ,_, whether_IN IRF7_JJ binds_NNS to_TO the_DT ISRE_NP of_IN LMP1p_NP was_VBD investigated_VBN by_IN EMSA_NP ._SENT BJAB_NP and_CC 293_CD cells_NNS were_VBD transfected_VBN with_IN IRF7_JJ or_CC its_PP$ mutants_NNS ,_, and_CC whole-cell_NN lysates_NNS were_VBD prepared_VBN for_IN EMSA_NP after_IN 48_CD h._NN The_DT ISRE_NP probe_NN that_WDT contains_VBZ LMP1p_NP ISRE_NP and_CC its_PP$ flanking_VBG sequences_NNS was_VBD synthesized_VBN and_CC labeled_VBN by_IN 32P_JJ ._SENT As_IN indicated_VBN in_IN Fig._NN ,_, the_DT Flag-tagged_JJ wild-type_NN IRF7A_NP and_CC IRF7(D477/479)_NP can_MD bind_VB to_TO the_DT ISRE_NN plus_CC flanking_VBG sequences_NNS of_IN LMP1p_NP (_( see_VB details_NNS in_IN Materials_NNS and_CC Methods_NNS )_) specifically_RB ._SENT However_RB ,_, binding_VBG of_IN IRF7-DeltaID_JJ (_( Delta247-467_JJ )_) ,_, which_WDT can_MD activate_VB both_DT LMP1p_NP and_CC IFNbetap_NP in_IN both_DT BJAB_NP and_CC 293_CD cells_NNS ,_, was_VBD not_RB detected_VBN (_( Fig._NN ,_, lane_NN 7_CD )_) but_CC did_VBD produce_VB a_DT weak_JJ signal_NN in_IN the_DT supershift_NN assay_NN (_( Fig._NN ,_, lane_NN 12_CD )_) ._SENT So_RB it_PP seems_VBZ that_IN this_DT IRF7_JJ mutant_NN has_VBZ very_RB weak_JJ DNA-binding_NP activity_NN ._SENT Consistent_JJ with_IN this_DT result_NN ,_, this_DT mutant_NN could_MD activate_VB the_DT IFNA4_NP promoter_NN but_CC it_PP could_MD not_RB be_VB detected_VBN by_IN EMSA_NP as_IN binding_VBG to_TO the_DT PRDI-III_NP sequences_NNS in_IN this_DT promoter_NN ._SENT Recently_RB ,_, Yang_NP et_FW al._FW showed_VBD that_IN this_DT IRF7_JJ mutant_NN could_MD activate_VB transcription_NN in_IN insect_NN cells_NNS but_CC that_IN it_PP had_VBD very_RB weak_JJ DNA-binding_NP activity_NN ._SENT Actually_RB ,_, some_DT IRF7_JJ protein-DNA_NN complexes_NNS are_VBP not_RB readily_RB detected_VBN by_IN EMSA_NP ._SENT IRF7-DN_NP ,_, which_WDT lacks_VBZ the_DT DBD_NN ,_, cannot_MD bind_VB to_TO the_DT ISRE_NP in_IN LMP1p_NP (_( Fig._NN ,_, lane_NN 9_CD )_) ._SENT When_WRB the_DT ISRE_NP sequence_NN in_IN the_DT probe_NN was_VBD mutated_VBN (_( see_VB details_NNS in_IN Materials_NNS and_CC Methods_NNS )_) ,_, no_DT specific_JJ band_NN was_VBD detected_VBN with_IN cell_NN lysates_NNS from_IN cells_NNS transfected_VBN with_IN wild-type_NN IRF7_JJ or_CC any_DT IRF7_JJ mutant_NN (_( Fig._NN ,_, right_JJ panel_NN )_) ._SENT Supershift_NN assays_NNS with_IN monoclonal_NN Flag_NP antibody_NN confirmed_VBD that_IN the_DT protein-DNA_NN complex_NN contains_VBZ IRF7_JJ (_( Fig._NN ,_, lanes_NNS 10_CD to_TO 14_CD )_) ._SENT Exogenously_RB expressed_VBN IRF7_JJ induces_VBZ expression_NN of_IN LMP1_NP in_IN P3HR1_JJ cells_NNS ._SENT |_SYM To_TO determine_VB whether_IN the_DT levels_NNS of_IN endogenous_JJ LMP1_NP actually_RB change_VB when_WRB exogenous_JJ IRF7_JJ is_VBZ expressed_VBN ,_, we_PP transfected_VBD an_DT EBV-positive_JJ cell_NN line_NN exhibiting_VBG low_JJ levels_NNS of_IN LMP1_NP to_TO determine_VB whether_IN increased_VBN expression_NN of_IN LMP1_NP would_MD occur_VB when_WRB the_DT endogenous_JJ promoter_NN was_VBD activated_VBN by_IN IRF7_JJ ._SENT The_DT P3HR1_JJ genome_NN is_VBZ deleted_VBN from_IN the_DT EBNA2_NP gene_NN ,_, which_WDT transactivates_VBZ LMP1p_NP ,_, and_CC the_DT cells_NNS express_VBP very_RB low_JJ levels_NNS of_IN LMP1_NP ._SENT P3HR1_JJ cells_NNS were_VBD transfected_VBN with_IN increasing_VBG amounts_NNS of_IN IRF7_JJ and_CC cotransfected_JJ with_IN EBNA2_NP and_CC IRF7A_NP ._SENT The_DT Western_JJ blotting_VBG results_NNS demonstrated_VBD that_IN LMP1_JJ protein_NN levels_NNS increased_VBN with_IN increasing_VBG amounts_NNS of_IN transfected_JJ IRF7_JJ ._SENT LMP1_NP could_MD be_VB barely_RB detected_VBN in_IN the_DT vector-alone_JJ control_NN ,_, although_IN endogenous_JJ IRF7_JJ protein_NN was_VBD detected_VBN in_IN these_DT P3HR1_JJ cells_NNS (_( Fig._NN ,_, lane_NN 1_CD )_) ._SENT The_DT endogenous_JJ IRF7_JJ may_MD be_VB inactive_JJ and_CC therefore_RB does_VBZ not_RB detectably_RB induce_VB LMP1_NP ._SENT Transiently_RB transfected_JJ IRF7A_NP or_CC EBNA2_NP or_CC cotransfection_NN with_IN IRF7_JJ and_CC EBNA2_JJ each_DT resulted_VBN in_IN elevated_JJ LMP1_JJ protein_NN levels_NNS ._SENT These_DT results_NNS suggest_VBP that_IN IRF7A_NP can_MD upregulate_VB LMP1_JJ protein_NN levels_NNS in_IN the_DT context_NN of_IN the_DT EBV_NP genomic_NN ,_, native_JJ promoter_NN elements_NNS ._SENT To_TO confirm_VB this_DT interesting_JJ result_NN with_IN RPA_NP ,_, we_PP also_RB assayed_VBD LMP1_NP RNA_NP levels_NNS in_IN P3HR1_JJ cells_NNS after_IN transfection_NN ._SENT The_DT RPA_NP results_NNS show_VBP a_DT pattern_NN of_IN increase_NN in_IN LMP1_NP RNA_NP levels_NNS corresponding_JJ to_TO that_DT of_IN LMP1_JJ protein_NN (_( shown_VBN in_IN Fig._NN )_) ._SENT In_IN the_DT vector-alone_JJ control_NN ,_, endogenous_JJ LMP1_JJ mRNA_NN could_MD not_RB be_VB detected_VBN in_IN P3HR1_JJ cells_NNS ._SENT With_IN increasing_VBG amounts_NNS of_IN IRF7_JJ or_CC EBNA2_JJ or_CC the_DT combination_NN of_IN IRF7_NP and_CC EBNA2_NP ,_, the_DT LMP1_NP mRNA_NN level_NN is_VBZ elevated_VBN gradually_RB ._SENT By_IN titrating_VBG in_IN IRF7_JJ with_IN EBNA2_NP ,_, we_PP could_MD essentially_RB reconstitute_VB normal_JJ LMP1_JJ levels_NNS as_IN expressed_VBN in_IN the_DT parental_JJ JiJoye_NP cell_NN line_NN ._SENT Thus_RB ,_, IRF7_NP can_MD activate_VB the_DT endogenous_JJ LMP1_JJ promoter_NN independently_RB or_CC together_RB with_IN EBNA2_NP in_IN cell_NN culture_NN and_CC the_DT results_NNS confirm_VBP those_DT obtained_VBN with_IN the_DT promoter-reporter_NN assays_NNS ._SENT Our_PP$ results_NNS clearly_RB show_VBP that_IN IRF7_NP can_MD activate_VB the_DT LMP1_JJ promoter_NN by_IN binding_VBG to_TO its_PP$ ISRE_NN and_CC that_IN IRF7_NP can_MD directly_RB induce_VB LMP1_JJ expression_NN ._SENT Furthermore_RB ,_, the_DT study_NN with_IN IRF7_JJ deletion_NN mutants_NNS showed_VBD that_IN IRF7_JJ functional_JJ domains_NNS have_VBP similar_JJ functions_NNS for_IN two_CD different_JJ promoters_NNS ,_, IFNbetap_NP and_CC LMP1p_NP ,_, in_IN both_DT 293_CD and_CC BJAB_NP cells_NNS ._SENT Our_PP$ results_NNS with_IN IFNbetap_NP confirm_VBP those_DT of_IN Lin_NP et_FW al._FW ._SENT From_IN our_PP$ results_NNS together_RB with_IN those_DT from_IN the_DT study_NN of_IN Lin_NP et_FW al._FW ,_, it_PP can_MD be_VB concluded_VBN that_IN IRF7_JJ functional_JJ domains_NNS are_VBP constitutive_JJ and_CC independent_JJ of_IN its_PP$ targets_NNS and_CC cell_NN lines_NNS ._SENT It_PP has_VBZ been_VBN reported_VBN that_IN NF-kappaB_NP plays_VBZ an_DT important_JJ role_NN in_IN the_DT activation_NN of_IN IFNbetap_NP independently_RB of_IN the_DT IRF_NP family_NN ,_, but_CC no_DT NF-kappaB_NP binding_JJ site_NN has_VBZ been_VBN identified_VBN in_IN LMP1p_NP ._SENT It_PP is_VBZ unknown_JJ whether_IN IRF7_JJ can_MD activate_VB transcription_NN without_IN involvement_NN of_IN another_DT transcription_NN factor_NN ._SENT IRF3_NP has_VBZ been_VBN shown_VBN to_TO associate_VB with_IN IRF7_JJ in_IN IFN_NP gene_NN activation_NN ._SENT In_IN this_DT study_NN ,_, we_PP used_VBD a_DT constitutively_RB active_JJ form_NN of_IN IRF7_JJ ,_, IRF7(Delta247-467)_NP ,_, which_WDT cannot_MD dimerize_VB with_IN either_DT IRF3_NP or_CC IRF7_JJ ._SENT However_RB ,_, this_DT mutant_NN has_VBZ very_RB high_JJ activity_NN on_IN both_CC the_DT promoters_NNS ,_, indicating_VBG that_IN dimerization_NN is_VBZ not_RB necessary_JJ for_IN IRF7_JJ transactivation_NN ability_NN ,_, even_RB though_IN it_PP has_VBZ been_VBN reported_VBN that_IN artificially_RB induced_VBN IRF7_JJ dimers_NNS can_MD bind_VB DNA_NN and_CC induce_VB target_NN genes_NNS independently_RB of_IN phosphorylation_NN or_CC other_JJ downstream_JJ effects_NNS of_IN viral_JJ infection_NN ._SENT IRF7_JJ is_VBZ modified_VBN by_IN phosphorylation_NN after_IN exposure_NN to_TO various_JJ stimuli_NNS ,_, including_VBG viral_JJ infection_NN ,_, double-stranded_JJ RNA_NP ,_, chemotherapeutic_JJ DNA-damaging_NN drugs_NNS ,_, and_CC expression_NN of_IN specific_JJ viral_JJ gene_NN products_NNS such_JJ as_IN LMP1_NP ._SENT This_DT phosphorylation_NN is_VBZ thought_VBN to_TO regulate_VB IRF7_JJ activity_NN through_IN elements_NNS in_IN the_DT C_NP terminus_NN which_WDT dictate_VBP nuclear_JJ localization_NN ,_, dimer_NN formation_NN ,_, and_CC promoter_NN targeting_VBG ._SENT Two_CD groups_NNS reported_VBD different_JJ results_NNS in_IN investigations_NNS of_IN the_DT identity_NN of_IN phosphorylated_JJ sites_NNS needed_VBN for_IN IRF7_JJ transactivation_NN activity_NN ._SENT Marie_NP et_FW al._FW showed_VBD that_IN murine_JJ IRF7_JJ activity_NN is_VBZ dependent_JJ on_IN phosphorylation_NN of_IN serine-425/426_NN ,_, which_WDT correspond_VBP to_TO human_JJ IRF7A_NP serine-471/472_NN ._SENT Hiscott_NP and_CC colleagues_NNS showed_VBD that_IN human_JJ IRF7A_NP activity_NN depends_VBZ on_IN the_DT phosphorylation_NN of_IN serine-477/479_NN ._SENT Our_PP$ results_NNS at_IN least_JJS support_VB the_DT latter_NN ,_, but_CC we_PP did_VBD not_RB test_VB for_IN the_DT effect_NN of_IN serine-471/472_NN ._SENT Several_JJ studies_NNS have_VBP demonstrated_VBN that_IN LMP1_NP is_VBZ regulated_VBN by_IN virus-specific_JJ factors_NNS ,_, especially_RB EBNA2_NP and_CC EBNA-LP_NP ,_, mediated_VBN by_IN some_DT host_NN cellular_JJ factors_NNS that_WDT tether_VBP to_TO the_DT LMP1_JJ promoter_NN (_( ,_, ,_, ,_, -_: ,_, ,_, ,_, )_) ._SENT Actually_RB ,_, EBNA2_NP is_VBZ not_RB the_DT only_JJ viral_JJ activator_NN for_IN LMP1_NP ._SENT In_IN KSHV-infected_NP cells_NNS as_RB well_RB as_IN in_IN cells_NNS coinfected_VBN with_IN both_DT KSHV_NP and_CC EBV_NP ,_, LMP1_NP is_VBZ activated_VBN by_IN the_DT KSHV_NP antigen_NN latency-associated_VBD nuclear_JJ antigen_NN in_IN the_DT absence_NN of_IN EBNA2_NP ._SENT To_TO our_PP$ knowledge_NN ,_, no_DT report_NN has_VBZ shown_VBN that_IN LMP1_NP is_VBZ regulated_VBN directly_RB by_IN a_DT host_NN cellular_JJ factor_NN ._SENT In_IN this_DT study_NN ,_, we_PP demonstrated_VBD that_IN LMP1_NP can_MD be_VB activated_VBN by_IN cellular_JJ IRF7_JJ without_IN the_DT involvement_NN of_IN any_DT viral_JJ factor_NN ._SENT This_DT interesting_JJ finding_NN may_MD account_VB for_IN a_DT puzzling_JJ phenomenon_NN in_IN EBV_NP biology_NN :_: LMP1_NP is_VBZ expressed_VBN in_IN type_NN II_NP latency_NN but_CC EBNA2_NP is_VBZ absent_JJ in_IN type_NN II_CD cells_NNS ._SENT Type_NN II_NP latency_NN is_VBZ exemplified_VBN by_IN nasopharyngeal_JJ carcinoma_NN (_( NPC_NP )_) ,_, and_CC in_IN fact_NN ,_, Zhang_NP and_CC Pagano_NP have_VBP detected_VBN high_JJ levels_NNS of_IN expression_NN of_IN IRF7_JJ in_IN most_JJS NPC_NP tissues_NNS tested_VBD as_RB well_RB as_IN in_IN LMP1-positive_NP NPC_NP lines_NNS passaged_VBN in_IN nude_JJ mice_NNS (_( L._NP Zhang_NP and_CC J._NP S._NP Pagano_NP ,_, unpublished_JJ results_NNS )_) ._SENT So_IN the_DT LMP1_JJ levels_NNS detected_VBN in_IN type_NN II_NP cells_NNS may_MD be_VB the_DT consequence_NN of_IN IRF7_JJ expressed_VBN in_IN type_NN II_CD cells_NNS ._SENT Therefore_RB ,_, like_IN EBNA2_NP ,_, which_WDT is_VBZ the_DT key_JJ viral_JJ antigen_NN for_IN maintaining_VBG type_NN III_NP latency_NN ,_, IRF7_NP may_MD play_VB an_DT equally_RB important_JJ role_NN in_IN maintaining_VBG type_NN II_NP latency_NN through_IN regulation_NN of_IN LMP1_JJ expression_NN ._SENT IRF7_JJ functions_NNS as_IN a_DT multifunctional_JJ protein_NN ._SENT First_RB ,_, IRF7_JJ was_VBD cloned_VBN on_IN the_DT basis_NN of_IN its_PP$ ability_NN to_TO bind_VB to_TO and_CC repress_VB EBNA-1_NP Qp_NP in_IN EBV_NP type_NN III_NP latency_NN ._SENT Second_JJ ,_, IRF7_JJ ,_, like_IN other_JJ IRFs_NNS ,_, plays_VBZ a_DT primary_JJ role_NN in_IN regulating_VBG the_DT expression_NN of_IN type_NN I_PP IFN_NP genes_NNS in_IN virus-infected_JJ cells_NNS ._SENT Zhang_NP and_CC Pagano_NP showed_VBD that_IN IRF7_NP was_VBD involved_VBN in_IN the_DT activation_NN of_IN Tap-2_NP by_IN LMP1_NP in_IN B_NP lymphoma_NN cells_NNS ;_: Tap-2_JJ mutations_NNS are_VBP involved_VBN in_IN diseases_NNS associated_VBN with_IN the_DT immune_JJ system_NN ._SENT Moreover_RB ,_, IRF7_JJ has_VBZ properties_NNS consistent_JJ with_IN a_DT putative_JJ oncogene_NN (_( Zhang_NP et_FW al._FW ,_, unpublished_JJ )_) ._SENT Here_RB ,_, we_PP found_VBD that_IN IRF7_NP can_MD regulate_VB expression_NN of_IN a_DT viral_JJ gene_NN in_IN addition_NN to_TO host_VB cellular_JJ genes_NNS such_JJ as_IN IFNA_NP genes_NNS ._SENT Expression_NN of_IN IRF7_JJ mRNA_NN and_CC protein_NN is_VBZ clearly_RB inducible_JJ by_IN LMP1_NP in_IN EBV-infected_JJ cells_NNS ._SENT Since_IN LMP1_NP can_MD activate_VB NF-kappaB_NP and_CC since_IN there_EX is_VBZ an_DT NF-kappaB_NP binding_JJ site_NN in_IN the_DT IRF7_JJ promoter_NN ,_, it_PP is_VBZ likely_JJ that_IN IRF7_JJ induction_NN by_IN LMP1_NP is_VBZ mediated_VBN by_IN NF-kappaB_NP ,_, at_IN least_JJS in_IN part_NN ._SENT In_IN fact_NN ,_, Zhang_NP et_FW al._FW have_VBP found_VBN that_IN a_DT suppression_NN of_IN IkappaB_NP can_MD block_VB the_DT induction_NN of_IN IRF7_JJ by_IN LMP1_NP ._SENT Furthermore_RB ,_, overexpression_NN of_IN NF-kappaB_NP can_MD induce_VB IRF7_JJ expression_NN in_IN DG75_NP ,_, the_DT EBV-negative_NP BL_NP cell_NN line_NN ._SENT However_RB ,_, the_DT results_NNS of_IN a_DT promoter-reporter_NN assay_NN indicated_VBD that_IN LMP1_NP could_MD not_RB activate_VB IRF7_JJ promoter_NN constructs_NNS in_IN HeLa_NP cells_NNS ,_, suggesting_VBG that_IN IRF7_JJ induction_NN by_IN LMP1_NP is_VBZ cell_NN type_NN specific_NN and_CC that_DT NF-kappaB_NP activation_NN needs_VBZ cooperation_NN with_IN other_JJ transcription_NN factors_NNS ._SENT In_IN addition_NN to_TO induction_NN of_IN IRF7_JJ expression_NN ,_, LMP1_NP also_RB regulates_VBZ IRF7_JJ protein_NN activity_NN :_: LMP1_NP augments_VBZ the_DT phosphorylation_NN status_NN and_CC facilitates_VBZ the_DT nuclear_JJ localization_NN of_IN IRF7_JJ ._SENT Based_VBN on_IN our_PP$ results_NNS ,_, a_DT regulatory_JJ circuit_NN between_IN LMP1_NP and_CC IRF7_NP is_VBZ outlined_VBN :_: IRF7_JJ activates_VBZ the_DT LMP1_JJ promoter_NN by_IN binding_VBG to_TO its_PP$ ISRE_NP ,_, which_WDT results_VBZ in_IN LMP1_JJ protein_NN expression_NN ._SENT In_IN turn_NN ,_, the_DT LMP1_NP expression_NN can_MD induce_VB IRF7_JJ expression_NN and_CC regulate_VB its_PP$ protein_NN activity_NN ._SENT In_IN addition_NN ,_, IRF7_NP may_MD be_VB autoregulated_VBN through_IN binding_VBG of_IN IRF7_JJ protein_NN to_TO the_DT ISRE_NN in_IN the_DT first_JJ intron_NN or_CC the_DT IRF-E_NN in_IN the_DT IRF7_JJ promoter_NN since_IN IRF7_JJ is_VBZ capable_JJ of_IN binding_VBG to_TO these_DT elements_NNS ;_: preliminary_JJ results_NNS indicate_VBP that_IN IRF7_NP can_MD induce_VB the_DT IRF7_JJ promoter_NN in_IN transient_JJ transfection_NN assays_NNS (_( S._NP Ning_NP and_CC J._NP S._NP Pagano_NP ,_, unpublished_JJ results_NNS )_) ._SENT P3HR1_JJ cells_NNS are_VBP defective_JJ for_IN EBNA2_JJ expression_NN ;_: therefore_RB ,_, little_RB if_IN any_DT LMP1_NP is_VBZ detected_VBN ._SENT The_DT absence_NN of_IN LMP1_NP leads_VBZ to_TO low_JJ levels_NNS of_IN IRF7_JJ ._SENT We_PP show_VBP here_RB that_IN IRF7_NP can_MD induce_VB a_DT low_JJ level_NN of_IN LMP1_NP in_IN these_DT cells_NNS ._SENT However_RB ,_, since_IN EBNA2_NP is_VBZ totally_RB absent_JJ and_CC since_IN the_DT IRF7_JJ and_CC EBNA2_JJ inducing_VBG effects_NNS are_VBP independent_JJ and_CC EBNA2_NP is_VBZ the_DT stronger_JJR inducer_NN and_CC normally_RB necessary_JJ for_IN LMP1_JJ induction_NN ,_, the_DT level_NN of_IN LMP1_NP remains_VBZ subnormal_JJ in_IN P3HR1_JJ cells_NNS ._SENT Our_PP$ results_NNS suggest_VBP that_IN IRF7_NP potentiates_VBZ the_DT oncogenic_JJ effect_NN of_IN LMP1_NP ._SENT Since_IN LMP1_NP can_MD induce_VB IRF7_JJ ,_, the_DT net_JJ effect_NN should_MD be_VB augmented_VBN expression_NN of_IN this_DT EBV_NP oncoprotein_NN ._SENT In_IN other_JJ work_NN ,_, Zhang_NP et_FW al._FW have_VBP found_VBN that_IN IRF7_JJ by_IN itself_PP has_VBZ oncogenic_JJ properties_NNS in_IN 3T3_JJ cells_NNS ,_, as_RB determined_VBN by_IN focus_NN formation_NN and_CC colony_NN formation_NN as_RB well_RB as_IN production_NN of_IN tumors_NNS ,_, and_CC that_IN the_DT combination_NN of_IN LMP1_NP and_CC IRF7_NP produces_VBZ at_IN least_JJS additive_JJ effects_NNS (_( Zhang_NP et_FW al._FW ,_, unpublished_JJ )_) ._SENT Whether_IN IRF7_JJ is_VBZ essential_JJ for_IN effects_NNS of_IN LMP1_JJ including_VBG oncogenesis_NN remains_VBZ to_TO be_VB determined_VBN ._SENT IRF7_JJ upregulates_NNS the_DT LMP1_JJ promoter_NN in_IN BJAB_NP cells_NNS ._SENT IRF7_JJ upregulates_NNS the_DT LMP1_JJ promoter_NN in_IN BJAB_NP cells_NNS ._SENT (_( A_NP )_) Schematic_NP illustration_NN of_IN the_DT LMP1_JJ promoter_NN ._SENT Numbers_NNS indicate_VBP the_DT nucleotide_NN sites_NNS relative_JJ to_TO the_DT transcriptional_JJ start_NN site_NN ._SENT The_DT ISRE_NP sequence_NN is_VBZ shown_VBN ._SENT (_( B_NP )_) Promoter_NP activity_NN was_VBD monitored_VBN by_IN investigating_VBG luciferase_NN activity_NN ._SENT BJAB_NN cells_NNS were_VBD transfected_VBN with_IN pGL2(-512/+72)-luciferase_NN plasmid_NP (_( LMP1p_NP )_) and_CC IRF7_JJ or_CC with_IN IRF7_JJ plus_CC EBNA2_JJ ._SENT Luciferase_NP activity_NN was_VBD analyzed_VBN at_IN 48_CD h_NN after_IN transfection_NN ._SENT RLU_NN levels_NNS and_CC severalfold_NN activation_NN relative_JJ to_TO the_DT basal_JJ level_NN of_IN reporter_NN gene_NN in_IN the_DT presence_NN of_IN the_DT vector_NN after_IN normalization_NN with_IN beta-Gal_JJ activity_NN were_VBD measured_VBN ._SENT Equal_JJ amounts_NNS of_IN cell_NN lysates_NNS were_VBD assayed_VBN for_IN luciferase_NN activity_NN ._SENT Each_DT data_NNS point_NN represents_VBZ the_DT average_NN of_IN seven_CD to_TO nine_CD repeats_NNS in_IN five_CD independent_JJ experiments_NNS ._SENT Error_NN bars_NNS represent_VBP means_VBZ +-_JJ standard_JJ errors_NNS (_( SE_NP )_) ._SENT (_( C_LS )_) Western_JJ blot_NN analysis_NN showing_VBG that_DT IRF7_JJ was_VBD expressed_VBN in_IN transfected_JJ BJAB_NP cells_NNS ._SENT Monoclonal_NP IRF7_JJ antibody_NN was_VBD used_VBN at_IN a_DT dilution_NN of_IN 1:300_CD ._SENT A_DT total_NN of_IN 100_CD mug_NN of_IN protein_NN was_VBD loaded_VBN in_IN each_DT lane_NN ._SENT Tubulin_NP was_VBD used_VBN as_IN loading_VBG control_NN ._SENT Effect_NN of_IN IRF7_JJ mutants_NNS on_IN LMP1_NP and_CC IFN-b_NP promoters_NNS ._SENT Effect_NN of_IN IRF7_JJ mutants_NNS on_IN LMP1_NP and_CC IFN-b_NP promoters_NNS ._SENT (_( A_NP )_) Schematic_NP representation_NN of_IN the_DT IRF7_JJ mutants_NNS used_VBN in_IN this_DT study_NN ._SENT The_DT amino_NN acid_NN sequence_NN from_IN 468_CD to_TO 491_CD is_VBZ shown_VBN ,_, serines_NNS replaced_VBN with_IN phosphomimetic_JJ aspartic_JJ acids_NNS are_VBP in_IN bold_JJ ,_, and_CC the_DT sites_NNS are_VBP indicated_VBN as_IN subscripts_NNS ._SENT SRD_NP ,_, signal_NN response_NN domain_NN (_( 20_CD )_) ._SENT (_( B_NP )_) Comparison_NN of_IN the_DT effects_NNS of_IN IRF7_JJ mutants_NNS on_IN the_DT IFN-b_NN and_CC LMP1_JJ promoters_NNS in_IN 293_CD cells_NNS ._SENT 293_CD cells_NNS were_VBD transfected_VBN with_IN pGL3/IFNb-Luc_NN or_CC pGL2(2512/172)-Luc_NN and_CC a_DT series_NN of_IN expression_NN plasmids_NNS encoding_VBG IRF7_JJ or_CC IRF7_JJ mutants_NNS as_RB indicated_VBD ._SENT RLU_NN levels_NNS and_CC severalfold_NN activation_NN relative_JJ to_TO the_DT basal_JJ level_NN of_IN reporter_NN gene_NN in_IN the_DT presence_NN of_IN the_DT vector_NN after_IN normalization_NN with_IN b-Gal_JJ activity_NN were_VBD measured_VBN ._SENT Equal_JJ amounts_NNS of_IN cell_NN lysates_NNS were_VBD assayed_VBN for_IN luciferase_NN activity_NN ._SENT Each_DT data_NNS point_NN represents_VBZ the_DT average_NN of_IN seven_CD to_TO nine_CD repeats_NNS in_IN five_CD independent_JJ experiments_NNS ._SENT Error_NN bars_NNS represent_VBP means_VBZ 6_CD SE_NN ._SENT (_( C_LS )_) Western_JJ blot_NN analysis_NN of_IN transfected_JJ IRF7_JJ mutants_NNS ._SENT Monoclonal_NP Flag_NP antibody_NN M2_NP was_VBD used_VBN at_IN a_DT dilution_NN of_IN 1:3,000_CD ._SENT Lanes_NNS :_: 1_LS ,_, pCMV2-Flag_NP ;_: 2_LS ,_, IRF7A_NP ;_: 3_LS ,_, IRF7-DID_NP ;_: 4_LS ,_, IRF7-DCAD_NP ;_: 5_LS ,_, IRF7-DVAD_NP ;_: 6_CD ,_, IRF7-DCAD/ID_NP ;_: 7_CD ,_, IRF7-DNES_NP ;_: 8_CD ,_, IRF7(D475-479)_NP ;_: 9_CD ,_, IRF7(D483/487)_NP ;_: 10_CD ,_, IRF7(D477/479_NP )_) ._SENT The_DT ISRE_NP in_IN LMP1p_NP responds_VBZ to_TO IRF7_JJ ._SENT The_DT ISRE_NP in_IN LMP1p_NP responds_VBZ to_TO IRF7_JJ ._SENT IRF7_JJ and_CC pLRS(-259)-CAT_NN or_CC its_PP$ mutants_NNS as_RB indicated_VBD were_VBD transfected_VBN into_IN BJAB_NP cells_NNS ._SENT Transfected_JJ cells_NNS were_VBD collected_VBN after_IN 48_CD h_NN ,_, and_CC CAT_NP assays_NNS were_VBD performed_VBN ._SENT Equal_JJ amounts_NNS of_IN cell_NN lysates_NNS were_VBD used_VBN ._SENT The_DT CAT_NP signals_NNS were_VBD quantitated_VBN by_IN Molecular_NP Dynamics_NPS PhosphorImager_NP and_CC normalized_VBN with_IN beta-Gal_JJ activities_NNS ._SENT Each_DT data_NNS point_NN represents_VBZ the_DT average_NN of_IN eight_CD repeats_NNS in_IN two_CD independent_JJ experiments_NNS ._SENT Error_NN bars_NNS represent_VBP means_VBZ +-_NN SE_NNS ._SENT IRF7_JJ binds_NNS to_TO the_DT ISRE_NP in_IN LMP1p_NP ._SENT IRF7_JJ binds_NNS to_TO the_DT ISRE_NP in_IN LMP1p_NP ._SENT BJAB_NP cells_NNS were_VBD transfected_VBN with_IN 5_CD mug_NN of_IN Flag-tagged_NP 